SEC Form 4 · accession 0001179110-16-030984
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristi Snell
Officer — VP Research & CSO
Period of report
Oct 26, 2016
Accepted (ET)
Oct 28, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.53 | Oct 26, 2016 | A | 500,000 | A | — | Oct 26, 2026 | Common Stock | 500,000 | 500,000 | D |
| Stock Option (right to buy)F2 | $0.53 | Oct 26, 2016 | A | 500,000 | A | — | Oct 26, 2026 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1This stock option will vest and become exercisable in 4 equal semi-annual installments over a period of 2 years from 10/26/16.
- F2This stock option will vest and become exercisable in 4 equal semi-annual installments over a period of 2 years from 10/26/16, subject to and contingent upon shareholder approval of theamendments to the Issuer's 2014 Stock Option and Incentive Plan adopted by the Issuer's Board of Directors on 10/26/16.